Opaleye Management’s RAPT Therapeutics RAPT Stock Holding History

Opaleye Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,000	Closed	-$213K	–	60
2025 Q4	$213K	Buy	+150,000	New	+$4.66M	0.03%	53

Opaleye Management's RAPT Position: Q1 2026 in Review

Opaleye Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 150,000 shares — an estimated $213K sold.

Opaleye Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $213K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Opaleye Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Opaleye Management sold 150,000 RAPT Therapeutics shares in Q1 2026, an estimated $213K.
Opaleye Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Opaleye Management's RAPT Therapeutics position peaked at $213K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Opaleye Management's 13F filing for Q1 2026, filed 15 May 2026.